 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Matinas BioPharma stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:MTNB! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Matinas BioPharma stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nano-crystal (LNC) platform technology. The company’s LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT9001, a prescription-only omega-3 free fatty acid formulation for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients. In addition, it provides MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. Matinas BioPharma Holdings, Inc. has a research collaboration with the National Institute of Neurological Disorders and Stroke (NINDS) for the development of a novel therapy for the treatment of HIV, as well as with ViiV Healthcare to develop and evaluate formulations of antiviral drug candidates; and a feasibility collaboration with Genentech, Inc. for the development of oral formulations. The company was founded in 2013 and is based in Bedminster, New Jersey.
Average volume
8.16 million shs
MARKET CAP
$267.25 million
Stock exchange
NYSEAMERICAN
Buy this stock!
- Stephen Johnson
- March 13, 2021
- No Comments
How to buy Matinas BioPharma stocks?
Below is a quick guide on how to buy AMEX:MTNB stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Matinas BioPharma shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Matinas BioPharma – Search for “”AMEX:MTNB”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Matinas BioPharma stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Is Matinas BioPharma a buy right now?
4 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Matinas BioPharma in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Matinas BioPharma stock.
What stocks does BAMagazine like better than Matinas BioPharma?
Wall Street analysts have given Matinas BioPharma a “Buy” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but Matinas BioPharma wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
How to buy Matinas BioPharma stocks step by step guide
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:MTNB stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Matinas BioPharma stocks with a step by step approach.
Step 1: Open an Account with a Broker
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Matinas BioPharma stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Step 2: Verify your Account
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Step 3: Fund your eToro Account
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Step 4: Search for Matinas BioPharma stocks
Now that you’ve funded your eToro account, just type “AMEX:MTNB stocks” into the search bar at the top of the screen and press “trade”.
Step 5: Buy AMEX:MTNB
All that’s left is to buy some AMEX:MTNB stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
How And Where To Buy Stocks Conclusion
All in all, AMEX:MTNB is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Matinas BioPharma stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
When is Matinas BioPharma’s next earnings date?
Matinas BioPharma is scheduled to release its next quarterly earnings announcement on Monday, March 8th 2021.
View our earnings forecast for Matinas BioPharma.
How were Matinas BioPharma’s earnings last quarter?
Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) issued its earnings results on Friday, November, 6th. The company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). The business had revenue of $0.10 million for the quarter, compared to analysts’ expectations of $0.06 million.
View Matinas BioPharma’s earnings history.
What price target have analysts set for MTNB?
4 equities research analysts have issued 12 month price targets for Matinas BioPharma’s shares. Their forecasts range from $3.00 to $4.00. On average, they expect Matinas BioPharma’s stock price to reach $3.63 in the next twelve months. This suggests a possible upside of 197.1% from the stock’s current price.
View analysts’ price targets for Matinas BioPharma or view top-rated stocks among Wall Street analysts.
Who are Matinas BioPharma’s key executives?
Matinas BioPharma’s management team includes the following people:
Mr. Jerome D. Jabbour J.D., Co-Founder, CEO, Pres & Director (Age 47, Pay $644.79k)
Mr. Keith A. Kucinski CPA, M.B.A., Chief Financial Officer (Age 51, Pay $249.05k)
Dr. Theresa Matkovits, Chief Devel. Officer (Age 54, Pay $380.62k)
Dr. James J. Ferguson, Chief Medical Officer (Age 68, Pay $490.85k)
Dr. Hui Liu M.B.A., Ph.D., Chief Technology Officer (Age 54)
Dr. Raphael J. Mannino, Chief Scientific Officer (Age 74)
Ian Cooney, Director of Investor Relations & Corp. Devel.
Mr. Frank Calamusa, Exec. Director and Head of Manufacturing & Supply Chain
Where to Buy Matinas BioPharma Stocks Broker Reviews
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:MTNB stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
- eToro takes pride in keeping their customers safe, they follow strict data protection rules to keep access to sensitive information to a minimum. Any of the information you provide eToro is even protected by SSL encryption, this ensures that even if someone were to gain access to the servers all your data remains safe.
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
Excellent for both new and experienced traders
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Who are some of Matinas BioPharma’s key competitors?
Some companies that are related to Matinas BioPharma include Cara Therapeutics (CARA), Esperion Therapeutics (ESPR), Dyne Therapeutics (DYN), Annexon (ANNX), Vectura Group (VEGPF), VBI Vaccines (VBIV), Kadmon (KDMN), Amphastar Pharmaceuticals (AMPH), Aclaris Therapeutics (ACRS), Phibro Animal Health (PAHC), Protagonist Therapeutics (PTGX), Collegium Pharmaceutical (COLL), Provention Bio (PRVB), Vanda Pharmaceuticals (VNDA) and Clovis Oncology (CLVS).
View all of MTNB’s competitors.
What other stocks do shareholders of Matinas BioPharma own?
Based on aggregate information from BAMagazine, some companies that other Matinas BioPharma investors own include KushCo (KSHB), Gran Tierra Energy (GTE), ADMA Biologics (ADMA), Bionano Genomics (BNGO), Pennsylvania Real Estate Investment Trust (PEI), Cannabics Pharmaceuticals (CNBX), OrganiGram (OGI), Novan (NOVN), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).
Compliance
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
What is Matinas BioPharma’s stock symbol?
Matinas BioPharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “MTNB.”
Who are Matinas BioPharma’s major shareholders?
Matinas BioPharma’s stock is owned by a number of retail and institutional investors. Top institutional investors include Victory Capital Management Inc. (0.51%) and MONECO Advisors LLC (0.03%). Company insiders that own Matinas BioPharma stock include Adam K Stern, Herbert J Conrad, Jerome D Jabbour, Keith A Kucinski and Patrick G Lepore.
View institutional ownership trends for Matinas BioPharma.
Which major investors are selling Matinas BioPharma stock?
MTNB stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., and MONECO Advisors LLC.
View insider buying and selling activity for Matinas BioPharma or view top insider-selling stocks.
How do I buy shares of Matinas BioPharma?
Shares of MTNB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
What is Matinas BioPharma’s stock price today?
One share of MTNB stock can currently be purchased for approximately $1.22.
How much money does Matinas BioPharma make?
Matinas BioPharma has a market capitalization of $243.32 million and generates $90,000.00 in revenue each year. The company earns $-17,370,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.
How many employees does Matinas BioPharma have?
Matinas BioPharma employs 21 workers across the globe.
What is Matinas BioPharma’s official website?
The official website for Matinas BioPharma is www.matinasbiopharma.com.
Where are Matinas BioPharma’s headquarters?
Matinas BioPharma is headquartered at SUITE 302, 1545 ROUTE 206 SOUTH, BEDMINSTER, NJ 7921, United States.
How can I contact Matinas BioPharma?
Matinas BioPharma’s mailing address is SUITE 302, 1545 ROUTE 206 SOUTH, BEDMINSTER, NJ 7921, United States. The company can be reached via phone at +1-908-4431860 or via email at mtnb@jtcir.com
More information
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
Frequently asked questions
How can you buy Matinas BioPharma stock on the internet?
You can easily buy Matinas BioPharma stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Another option is using a regulated broker like IC Markets or Interactive Brokers. You can an account with these brokers and start buying or trading AMEX:MTNB stocks in a safe and complete environment to trade in.
Where to buy Matinas BioPharma stock?
You will first want to find a licensed broker that supports AMEX:MTNB stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:MTNB stocks in a safe and complete environment.
Is AMEX:MTNB stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:MTNB stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Matinas BioPharma stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:MTNB is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Matinas BioPharma stock.
How do you trade Matinas BioPharma stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Matinas BioPharma stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:MTNB stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Matinas BioPharma stock?
To sell your AMEX:MTNB stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Matinas BioPharma stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:MTNB stock.
Share this information
Share on facebook
Facebook
Share on twitter
Twitter
Stephen Johnson
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
Table of Contents
| |
Our score |
0% commission |
Other stocks
Related News
All EPA Stocks More Information EPA stocks What Is the Paris Stock Exchange (EPA)? Now
November 16, 2021
No Comments
November 16, 2021
No Comments
English 
Svenska 
Dansk 
Nederlands 
Suomi 
Eesti 
日本語